Federal Register / Vol. 80, No. 61 / Tuesday, March 31, 2015 / Notices 17045 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than April 24, 2015. 

A. Federal Reserve Bank of Kansas 

City (Dennis Denney, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001: 

1. Jones National Corporation, 

Seward, Nebraska; to acquire 100 

percent of the voting shares of 

Valparaiso Enterprises, Inc., and thereby 

indirectly acquire Oak Creek Valley 

Bank, both in Valparaiso, Nebraska. 

In connection with this application, 

Applicant also has applied to engage 

through Valparaiso Enterprises, Inc., 

Valparaiso, Nebraska, in general 

insurance activities in a town of less 

than 5,000 in population, pursuant to 

section 225.28(b)(11)(iii)(A). 

Board of Governors of the Federal Reserve 

System, March 26, 2015. 

Michael J. Lewandowski, 

Associate Secretary of the Board. 

[FR Doc. 2015–07295 Filed 3–30–15; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (12 U.S.C. 1817(j)) and 

section 225.41 of the Board’s Regulation 

Y (12 CFR 225.41) to acquire shares of 

a bank or bank holding company. The 

factors that are considered in acting on 

the notices are set forth in paragraph 7 

of the Act (12 U.S.C. 1817(j)(7)). 

The notices are available for 

immediate inspection at the Federal 

Reserve Bank indicated. The notices 

also will be available for inspection at 

the offices of the Board of Governors. 

Interested persons may express their 

views in writing to the Reserve Bank 

indicated for that notice or to the offices 

of the Board of Governors. Comments 

must be received not later than April 15, 

2015. 

A. Federal Reserve Bank of 

Minneapolis (Jacquelyn K. Brunmeier, 

Assistant Vice President) 90 Hennepin 

Avenue, Minneapolis, Minnesota 

55480–0291: 

1. The Belva H. Rasmussen 2012 

Irrevocable Trust, Roseville, Minnesota, 

Pamela M. Harris, Falcon Heights, 

Minnesota, and Eva B. Rasmussen, 

Edina, Minnesota, individually and as 

trustees, and Benjamin T. Rasmussen, 

Edina, Minnesota, to retroactively join 

the Rasmussen Family Control Group; to 

acquire voting shares of Northeast 

Securities Corporation, Minneapolis, 

Minnesota; and thereby indirectly 

acquire voting shares of Northeast Bank, 

Minneapolis, Minnesota. 

Board of Governors of the Federal Reserve 

System, March 26, 2015. 

Michael J. Lewandowski, 

Associate Secretary of the Board. 

[FR Doc. 2015–07296 Filed 3–30–15; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel 

Development of Informatics Technology. 

Date: April 15–16, 2015. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W538, Rockville, MD 20850, (Telephone 

Conference Call). 

Contact Person: Nicholas Kenney, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, 9609 Medical Center Drive, 

Room 7W246, Rockville, MD 20850, 240– 

276–6374, nicholas.kenney@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/sep/sep.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: March 26, 2015. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–07340 Filed 3–30–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Notice for Public Comment on the 

Child Abuse Prevention and Treatment 

Act (CAPTA) 

AGENCY: Children’s Bureau; 

Administration on Children, Youth and 

Families; ACF, HHS. 

ACTION: Notice. 

SUMMARY: Pursuant to 42 U.S.C. 5106a, 

the Children’s Bureau (CB) announces 

the opportunity for public comment on 

the policy interpretation of section 

106(b)(2)(B)(x) articulated in question 

2.1A.4 #8 of the Child Welfare Policy 

Manual (CWPM), which concerns the 

public disclosure of findings or 

information about a case of child abuse 

or neglect which results in a child 

fatality or near fatality. 

DATES: Submit written or electronic 

comments on or before June 29, 2015. 

ADDRESSES: Interested persons may 

submit comments to http://

www.regulations.gov/. We urge you to 

submit comments electronically to 

ensure they are received in a timely 

manner. Written comments may also be 

submitted to Kathleen McHugh, United 

States Department of Health and Human 

Services, Administration for Children 

and Families, Policy Division, 8th Floor, 

1250 Maryland Avenue, SW., 

Washington, DC 20024. 

FOR FURTHER INFORMATION CONTACT: 

Kathleen McHugh, United States 

Department of Health and Human 

Services, Administration for Children 

and Families, Policy Division, 8th Floor, 

1250 Maryland Avenue, SW., 

Washington, DC 20024. Email address: 

cbcomments@acf.hhs.gov. 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
17046 Federal Register / Vol. 80, No. 61 / Tuesday, March 31, 2015 / Notices 

SUPPLEMENTARY INFORMATION: Section 

106(b)(2)(B)(x) of CAPTA requires a 

certification by the State Governor that 

the State has in effect and is enforcing 

a State law, or has in effect and is 

operating a statewide program, relating 

to child abuse and neglect that includes 

‘‘provisions which allow for public 

disclosure of the findings or information 

about the case of child abuse or neglect 

which has resulted in a child fatality or 

near fatality.’’ We revised our policy 

interpretation of the statutory provision 

regarding public disclosure of 

information in cases of child abuse or 

neglect which have resulted in a child 

fatality or near fatality found in section 

106(b)(2)(B)(x) of CAPTA in September 

2012 with the addition of CWPM 

question 2.1A.4 #8. This interpretation 

requires States to develop procedures 

for the release of information including, 

but not limited to: the cause of and 

circumstances regarding the fatality or 

near fatality; the age and gender of the 

child; information describing any 

previous reports or child abuse or 

neglect investigations that are pertinent 

to the child abuse or neglect that led to 

the fatality or near fatality; the result of 

any such investigations; and the 

services provided by and actions of the 

State on behalf of the child that are 

pertinent to the child abuse or neglect 

that led to the fatality or near fatality. 

States may allow exceptions to the 

release of information in order to ensure 

the safety and well-being of the child, 

parents and family or when releasing 

the information would jeopardize a 

criminal investigation, interfere with the 

protection of those who report child 

abuse or neglect or harm the child or the 

child’s family. States must also ensure 

compliance with other federal 

confidentiality restrictions when 

implementing the confidentiality 

provisions under CAPTA, including the 

confidentiality requirements applicable 

to titles IV–B and IV–E of the Social 

Security Act (the Act) and in accordance 

with 45 CFR 1355.30, which requires 

that records maintained under title IV– 

E and IV–B of the Act are subject to the 

confidentiality provisions in 45 CFR 

205.50. Among other things, 45 CFR 

205.50 restricts the release or use of 

information concerning individuals 

receiving financial assistance under 

these programs to certain persons or 

agencies that require the information for 

specified purposes. 

We also revised several CWPM 

answers in section 2.1A to bring them 

in line with the policy as outlined in the 

new question and answer (Q/A). CWPM 

section 2.1A.1, questions 1, 2, 6, and 8; 

and CWPM section 2.1A.4, questions 3, 

4, 5, 6, and 7 were all revised. At that 

time, Q/A 2.1A.4 #2, was deleted, but it 

was updated and reissued in August 

2013. This Q/A clarifies that when child 

abuse or neglect results in the death or 

near death of a child, the State must 

provide for the disclosure of the 

information required by section 2.1A.4, 

Q/A #8 of the CWPM, but that the 

provision should not be interpreted to 

require disclosure of information which 

would fall within the specific 

exceptions that states are allowed to 

establish under section 2.1A.4, Q/A #8 

of the CWPM. The full Q/A 2.1A.4 #2 

can be found at: http://www.acf.hhs.gov/ 

cwpm/programs/cb/laws_policies/laws/

cwpm/policy_dsp.jsp?citID=68#320. The 

history of the modified Q/A’s is also 

available in the CWPM at: http://

www.acf.hhs.gov/cwpm/programs/cb/

laws_policies/laws/cwpm/policy_

dsp.jsp?citID=68#2561). 

We seek comment from state agencies 

and other stakeholders about the revised 

policy interpretation at CWPM, section 

2.1A.4, Q/A #8, or any other revised 

policies in section 2.1A of the CWPM 

noted above. 

We encourage stakeholder 

respondents to address the following 

questions: 

(1) Please describe any challenges 

you’ve had obtaining information about 

child fatalities and near fatalities which 

resulted from child abuse and neglect 

from a state. Have there been 

improvements in obtaining the 

information since CB revised the policy 

in CWPM section 2.1.A in September 

2012? 

(2) What concerns, if any, do you have 

with the definition of near fatalities in 

a state? 

(3) Has a state responded that the state 

cannot disclose information due to 

confidentiality protections? If so, 

describe the information requested and 

the confidentiality provision cited by 

the state. 

(4) Does your state offer a public 

report of the child fatalities review 

panel/commission? If so, does the report 

contain the required disclosure of 

information? Is the report a barrier to 

obtaining information? 

We encourage state agency 

respondents to address the following 

questions: 

(1) What challenges, if any, have you 

faced implementing the revised policy? 

Has the revised policy improved your 

disclosure process and policies? 

(2) Are there challenges in applying 

the disclosure policy while also 

ensuring that you adhere to 

confidentiality protections? 

Dated: March 24, 2015. 

Mark H. Greenberg, 

Acting Assistant Secretary for Children and 

Families. 

[FR Doc. 2015–07390 Filed 3–30–15; 8:45 am] 

BILLING CODE 4184–29–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: AIDS and AIDS Related Research. 

Date: April 8, 2015. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Mary Clare Walker, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5208, 

MSC 7852, Bethesda, MD 20892, (301) 435– 

1165, walkermc@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Topics in 

Bacterial Pathogenesis. 

Date: April 9, 2015. 

Time: 10:00 a.m. to 11:00 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Marci Scidmore, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3192, 

MSC 7808, Bethesda, MD 20892, 301–435– 

1149, marci.scidmore@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 


asabaliauskas on DSK5VPTVN1PROD with NOTICES